Skip to main content

CASE REPORT article

Front. Pediatr., 03 October 2018
Sec. Pediatric Cardiology

Infective Endocarditis, a Rare Complication of Late Neonatal Group B Strep Sepsis

\r\nDaniel McLennan,*Daniel McLennan1,2*Gareth MorganGareth Morgan1
  • 1The Heart Institute, Children's Hospital Colorado, Denver, CO, United States
  • 2Heart Centre for Children, The Children's Hospital at Westmead, Sydney Children's Hospitals Network, Sydney, NSW, Australia

Background: Infective endocarditis (IE) is extremely rare in infants with structurally normal hearts. We present a case of Group B Streptococcus (GBS) endocarditis in a 5 week old.

Clinical Case: A 5-week old male presented to his local hospital with fever and was diagnosed with GBS sepsis. He received 4 days of intravenous antibiotics and was discharged home with 6 days of oral antibiotics. He re-presented 5 days after discharge with severe sepsis as well as a new pathological pan systolic murmur and was diagnosed with IE following echocardiographic identification of a mitral valve vegetation. He was subsequently transferred to a tertiary cardiology center. Ten days after readmission he developed an intracranial hemorrhage associated with rupture of a mycotic aneurysm requiring emergency evacuation.

Conclusion: Late-onset GBS sepsis is rare, but when improperly treated can have severe consequences. Infant IE is extremely rare. When diagnosed prompt treatment must be initiated to provide the best outcome for the patient, including consideration of surgical removal of the vegetation.

Introduction

A 5-week old boy presented to the emergency department of a peripheral hospital with fever, irritability, lethargy, poor feeding, and tachycardia. Blood culture grew Group B Streptococcus (GBS). He was treated with intravenous (IV) Ampicillin and Gentamicin for 4 days and discharged home on oral ampicillin for a further 6 days. He re-presented 5 days after discharge with hypotension, tachycardia, poor peripheral perfusion and in severe septic shock. He was noted to have a new pan-systolic murmur. Pending the results of blood cultures, he was started on intravenous ceftriaxone and ampicillin. An Echocardiogram demonstrated a structurally and functionally normal heart with normal sized cardiac chambers. There was a 2.7 mm vegetation on what appeared to be a normal anterior mitral leaflet, causing mitral regurgitation, suggesting infective endocarditis (IE) (1) (Figures 1, 2).

FIGURE 1
www.frontiersin.org

Figure 1. Trans-thoracic echocardiography apical four chamber view demonstrating the left ventricle (Star), left atrium (Triangle) and the mobile vegetation attached to the anterior leaflet of the mitral valve (Arrow).

FIGURE 2
www.frontiersin.org

Figure 2. (A) Trans thoracic echocardiography parasternal long axis of the heart demonstrating the left ventricle (Star), left atrium (Triangle) and the mobile vegetation attached to the anterior leaflet of the mitral valve (Arrow). The vegetation measured 2.7 mm (B) The color Doppler comparison demonstrates the regurgitation from the anterior leaflet of the mitral valve secondary to the vegetation.

The patient's mother was 21 years old with one older son. She tested positive to GBS during the first pregnancy, but tested negative during this one. According to guidelines from the Royal Australian and New Zealand College of Obstetricians and Gynecologists, she did not meet the criteria to receive antibiotic prophylaxis against GBS for this delivery. Her older child had no significant medical issues during his infancy.

The patient was transferred to a tertiary referral center for cardiac evaluation and antibiotic treatment. A repeat echocardiogram confirmed the mobile 2.7 mm vegetation from the anterior mitral leaflet, along with mild mitral regurgitation. The decision was made to treat with IV antibiotics and observe progress. On the 7th day of IV antibiotics, the mitral valve vegetation was noted to be smaller, now measuring 1.9 mm. The patient remained asymptomatic at this stage.

On the tenth day of IV antibiotics, he had fluctuating conscious levels with focal seizure activity lasting 20–30 s at a time. His fontanelle was noted to be bulging. He had a code called and was transferred and stabilized in the intensive care unit. The next morning in the intensive care he became unstable with bradycardia and hypertension with a systolic pressure of 90 and low diastolic pressure of 25. He underwent emergency brain computerized tomography which showed a large intracranial hemorrhage at the site of the left middle cerebral artery (MCA). He underwent emergency neurosurgery to evacuate the hemorrhage. The surgery revealed a ruptured area of an aneurysm felt to be a ruptured mycotic aneurysm.

Over the following 2 months, he underwent repeat neurosurgical procedures and had a flap of skull removed to allow decompression of the brain. He completed a 6-week course of IV Benzyl-penicillin with complete resolution of the vegetative lesion and only mild mitral regurgitation. He was left with dense right hemiplegia, for which he is receiving rehabilitation.

Discussion

The incidence of late-onset GBS (Infection between 7 days of life and 3 months) occurs in approximately 0.27 per 1,000 births. Evidence has shown that intrapartum chemo-prophylaxis does not prevent the occurrence of late-onset GBS (24). When GBS sepsis is found or suspected, and there is no source then current guidelines recommend empirical antibiotic treatment with ampicillin plus gentamicin or cefotaxime until organism and susceptibility are found. If group B strep is confirmed, then intravenous penicillin therapy is commenced for a minimum of 10 days (4, 5). If a specific source of infection is found, then longer therapy times are required, such as meningitis (14–21 days) or IE (6 weeks).

IE accounts for between 1 in 1300 to 3500 hospital admission in children with a mortality rate of 2–5% (5, 6). Of the cases of infective endocarditis that are seen in a hospital, group B strep accounts for only 2% of the cases. 40% of cases of IE have previous congenital heart disease. Only 4% of cases of IE will occur in infants under 1 year of age without congenital heart disease (1, 7).

Neurological manifestations of IE occur in up to 30% of cases being the presenting symptoms in 16–23% of patients, and intracranial mycotic aneurysms (ICMA) occur in 2% of cases. (8, 9) In up to 30% of cases, neurologic complications occur after the initiation of antimicrobial therapy, usually within 2 weeks after treatment has begun. Three-quarters of all ICMAs affect the middle cerebral artery (8). For patients with unruptured ICMAs, the mortality rate is 30%; after rupture, the mortality rate approaches 80% (8). However, more recent publications have reported mortality rates of ruptured ICMA at 12–32% (10).

In this case, the diagnosis of IE was made by demonstrating recurrent positive bacterial cultures, along with echocardiographic evidence of vegetative lesions (see Table 1) (1). The suspicion of IE came after clinical examination identified a new murmur. Almost all children with confirmed IE have a new murmur as part of their presentation. Only 70% of patients with infective endocarditis will have positive blood cultures. In those that have blood cultures obtained before any antimicrobial therapy is given, this number rises to more than 90% (11). It is therefore imperative in any patient presenting with sepsis and a new murmur that at least two separate blood cultures are taken before antibiotics are started.

TABLE 1
www.frontiersin.org

Table 1. Modified duke criteria for infective endocarditis.

This case highlights some key points in the management of neonates and sepsis. It is hard to know whether the initial presentation was due to IE or bacteremia. Once GBS is confirmed a source should be looked for. If no source is found then, IV antibiotics should be administered for a minimum of 10 days. GBS is very sensitive to penicillin's, but incompletely treated it can be a very virulent bacterium.

When a new pathological murmur is heard in association with sepsis and/or bacteremia IE should be high on the differential diagnosis list, and an urgent echocardiogram must be sought (1). If the IE involves left-sided heart structures, neurological complications can occur. It is important to perform a regular neurological examination, and appropriate imaging should be undertaken when there are neurological signs or symptoms.

Guidelines for the surgical management of pediatric infective endocarditis do not currently exist due to the lack of data in the pediatric population. In 2015 the American Heart Association released a scientific statement on infective endocarditis in childhood. They state that surgical intervention can be lifesaving and often urgently necessary. But they state it must be individualized as the surgical management to date is an extension from experts in the management of adults with IE. They provide a list of recommendations for when surgery may be considered, which includes left-sided lesions especially involving the anterior mitral valve leaflet. An embolic event within 2 weeks of treatment, valve perforation and other factors (12). Our patient would have fulfilled several of these criteria.

In the same year, the European Society of Cardiology released a guideline on the management of vegetation in IE, which outlines for each bacteria and each location what the ideal management should be. It also gives guidance on the neurological concerns and when to image. The guideline recommends that due to the aggressive nature of GBS, surgery should be performed as an emergency to remove the vegetation (9). It also recommends that for left-sided lesions larger than 10 mm, on the anterior leaflet, that is mobile, due to the risk of embolization emergency surgery should be performed (9). Some centers advocate for early surgery (within 3 days of diagnosis) in patients with left-sided vegetation's due to the risk of septic emboli (13).

Our patient did not receive surgery, as our institution felt that the lesion was not causing significant enough valve regurgitation and was not large enough to warrant surgical removal. He then became too unstable with the intracranial hemorrhage to consider surgical removal acutely as he was too unsuitable for by-pass surgery and was treated conservatively. This fits with the ESC guidelines recommending not to perform surgical removal of the vegetation for 4 weeks post intracranial bleed. In this case, the vegetation had resolved within the 4 week period.

Lessons For Practice

(1) Neonatal GBS IE is extremely rare.

(2) Late-onset GBS sepsis is an uncommon problem that when improperly treated can have severe consequences. It is important to follow appropriate antibiotic guidelines and investigate for possible sources.

(3) When suspecting IE or when there is a new pathological murmur in the background of sepsis or bacteremia follow the modified Duke criteria.

(4) IE can have multiple organ sequelae such as intracranial abscess, glomerulonephritis, and mycotic aneurysms. When investigating, managing and treating patients with IE all these possible associated pathologies must be investigated thoroughly and considered if any change is seen in the patients clinical status.

(5) When treating patients with IE, it is important to consult the latest guideline or hospital protocol in regards to vegetative lesions. If surgery is indicated then prompt decision-making and emergency surgery is key to positive outcomes.

Ethics Statement

The study is a retrospective case report on established, accepted practices, but combined in a new way to benefit the patient, hence no ethnical approval is required. The draft paper was sent to the patient and family. After review of the paper, the family provided written consent for this publication.

Author Contributions

DM substantial contributions to the conception or design of the work. DM and GM drafting the work or revising it critically for important intellectual content.

Funding

This Report was not funded. It was the sole work of the authors.

Disclaimer

This article, paper, and report presents independent research. The views expressed are those of the authors.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The reviewer DI declared a shared affiliation, though no other collaboration, with the authors to the handling editor.

References

1. Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, et al. Unique features of infective endocarditis in childhood. Pediatrics (2002) 109:931–43. doi: 10.1542/peds.109.5.931

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Centers for Disease Control and Prevention (CDC). Early onset and late onset neonatal group B streptococcal disease-United States, 1996–2004. MMWR Morb Mortal Wkly Rep. (2005) 54:1205–8.

Google Scholar

3. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA (2008) 299:2056. doi: 10.1001/jama.299.17.2056

PubMed Abstract | CrossRef Full Text | Google Scholar

4. American Academy of Pediatrics. Group B streptococcal infections. In: Kimberlin DW, editor. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th Edn. American Academy of Pediatrics (2015). P. 745.

Google Scholar

5. American Academy of Pediatrics. Tables of antibacterial drug dosages, Table 4.2. In: Kimberlin DW, editor. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th Edn. Elk Grove Village, IL: American Academy of Pediatrics (2015). P. 882.

6. Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation (2009) 119: 865–70. doi: 10.1161/CIRCULATIONAHA.108.798751

PubMed Abstract | CrossRef Full Text

7. Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y. Changing spectrum of infective endocarditis: a review of 194 episodes over 20 years. Circ J. (2003) 67:3–7. doi: 10.1253/circj.67.3

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Tunkel AR, Kaye D. Neurologic complications of infective endocarditis. Neurol Clin. (1993) 11:419–40. doi: 10.1016/s0733-8619(18)30161-0

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Zotti FD, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. (2015) 36:3075–128. doi: 10.1093/eurheartj/ehv319

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Kannoth S, Thomas S. Intracranial microbial aneurysm (infectious aneurysm): current options for diagnosis and management. Neurocrit Care (2009) 11:120–9. doi: 10.1007/s12028-009-9208-x

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Park MK. Park's the Pediatric Cardiology Handbook: Mobile Medicine Series. Elsevier Saunders Publishing (2016). p. 224.

12. Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB, et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation (2015) 132:1487–515. doi: 10.1161/CIR.0000000000000298

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Shamszad P, Khan M, Rossano J, Fraser CD Jr. Early surgical therapy of infective endocarditis in children: a 15-year experience. J Thorac Cardiovasc Surg. (2013) 146:506–11. doi: 10.1016/j.jtcvs.2012.12.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: infective endocarditis, group B streptococcus, neonate, mycotic aneurysm, hemorrhagic stroke

Citation: McLennan D and Morgan G (2018) Infective Endocarditis, a Rare Complication of Late Neonatal Group B Strep Sepsis. Front. Pediatr. 6:274. doi: 10.3389/fped.2018.00274

Received: 05 September 2017; Accepted: 11 September 2018;
Published: 03 October 2018.

Edited by:

Oswin Grollmuss, Université Paris-Sud, France

Reviewed by:

Giuseppina Milano, Lausanne University Hospital (CHUV), Switzerland
Dunbar Ivy, University of Colorado, United States

Copyright © 2018 McLennan and Morgan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Daniel McLennan, mclennan.daniel@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.